Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Devonian Health Group Inc DVHGF


Primary Symbol: V.GSD

Healthcare
Devonian Health Group Inc. is a Canada-based late-stage botanical pharmaceutical company. The Company's main activity is the development of botanical drugs from plant materials and algae for the treatment of inflammatory-autoimmune diseases, including ulcerative colitis and atopic dermatitis. It is also involved in the development of value-added products for dermo-cosmetics and the distribution... see more

Recent & Breaking News (TSXV:GSD)

Devonian Health Group Reports Second Quarter 2024 Financial Results and Business Update

Business Wire March 28, 2024

Devonian Announces Closing of a Private Placement of Units

Business Wire March 14, 2024

Devonian Names Kathryn J. Gregory to the Board of Directors and Grants Stock Options

Business Wire February 29, 2024

Devonian Announces that its Subsidiary, Altius, Launches Authorized Generic of Dexlansoprazole (Dexilant®) in Canada

Business Wire February 27, 2024

Devonian Announces a $2.16 Million Secured Term Loan Following Repayment of $3.5 Million Long Term Loan

Business Wire February 26, 2024

Devonian Announces the Results of its Annual General and Special Shareholders' Meeting, the Approval of Amendments to its Stock Option Plan, and Grant of Stock Options

Business Wire February 21, 2024

Devonian Bolsters Intellectual Property With Issuance of U.S. Patent Covering a Method of Treatment of Inflammatory Bowel Disease

Business Wire February 20, 2024

Devonian Seeks Shareholders Approval for Share Consolidation

Business Wire January 19, 2024

Devonian Bolsters Leadership Team and Aligns Strategy to Accelerate Clinical Development and Drive Revenue Growth and Commercial Success

Business Wire December 4, 2023

Devonian Files Patent Cooperation Treaty (PCT) Application for Thykamine(TM) in Wound Healing

Business Wire November 8, 2023

Devonian Announces Closing of a Private Placement of $500,000

Business Wire September 1, 2023

Devonian Health Group Receives a Notice of Allowance for Issuance of a U.S. Patent On a Method of Treatment of Inflammatory Bowel Disease.

Business Wire June 20, 2023

Devonian Announces Closing of a Private Placement of $1.2 Million

Business Wire June 6, 2023

Devonian Announces Private Placement of up to $5 Million

Business Wire May 19, 2023

Devonian Health Group Announces Presentation of Thykamine(TM) Efficacy Results in Atopic Dermatitis at the World Congress of Dermatology and Provides Thykamine(TM) Clinical Development Program Update.

Business Wire May 16, 2023

Devonian Health Group Announces the Appointment of New Board Members and Grant of Stock Options

Business Wire May 12, 2023

Devonian Announces Filing of Preliminary Base Shelf Prospectus

Business Wire May 11, 2023

Devonian Announces Approval of Amendments to its Stock Option Plan and its Restricted Share Unit Plan

Business Wire March 30, 2023

Devonian Health Group Announces voting results of the Annual General and Special Meeting and welcome new board members

Business Wire March 24, 2023

Devonian Health Group Announces Hybrid Shareholders' Annual General and Special Meeting

Business Wire February 22, 2023